StockData
Actuate Therapeutics, Inc. logo

Actuate Therapeutics, Inc. (ACTU) stock

ACTUNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 0/30
$0.25−0.01 (-2.38%)

Close on Nov 18, 2026Market cap $5.90MP/E –Yield –

Actuate Therapeutics free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

No free cash flow figures for Actuate Therapeutics

Actuate Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Actuate Therapeutics figures

See a number that looks wrong?